You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

Browse

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Erratum

Therapeutic Advances in Pulmonary and Critical Care Medicine

Impact Factor: 3.0 / 5-Year Impact Factor: 3.0

Journal Homepage Submission guidelines

Restricted access

Correction

First published online 2022

Erratum

, , [...], and

All Articles

https://doi.org/10.1177/11795484221127555

Abstract

Get full access to this article

View all access options for this article.

References

Jones

Smith

Berg

, et al. Efficacy and Safety of LY3127804, an Anti-Angiopoietin-2 Antibody, in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial in Patients Hospitalized with Pneumonia and Presumed or Confirmed COVID-19. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine. January 2022. doi:10.1177/11795484221119316

Browse journal

Current issue OnlineFirst All issues